United Kingdom · Question · Written question
UIN 16569
Menopause: Drugs
Original
Introduced
7 July 2026
Last action
15 July 2026 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
15 July 2026
Summary
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure consistent access across Integrated Care Boards to non-hormonal menopause treatments, including fezolinetant.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
7 July 2026
Written question
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure consistent access across Integrated Care Boards to non-hormonal menopause treatments, including fezolinetant.
Source: Commons
15 July 2026
Answer
The National Institute for Health and Care Excellence (NICE) published guidance on 31 March 2026 recommending fezolinetant as an option for treating moderate to severe menopause-related hot flushes and night sweats when hormone replacement therapy is unsu...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2026-07-07/16569
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1925141
- uk · wq-1925141 · source updated 15 July 2026